Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90600951 | 9060095 | 1 | I | 20121221 | 0 | 20130207 | 20130207 | DIR | 0.00 | M | N | 160.00000 | LBS | 20130129 | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90600951 | 9060095 | 1 | PS | PEGASYS GENENTECH (ROCHE) | 1 | INTRAVENOUS | 180 MCG 1/WEEK INTRAVENOUS | N | 0 | 180 | MCG | X1QW | |||||||
| 90600951 | 9060095 | 2 | SS | RHINOCORT | 1 | 800/1000 DAILY ORAL | 20746 | 800/1000 | MG | QD | |||||||||
| 90600951 | 9060095 | 3 | SS | INCIVEK | 1 | ORAL | DAILY ORAL | 201917 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90600951 | 9060095 | 1 | Hepatitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 90600951 | 9060095 | HO |
| 90600951 | 9060095 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90600951 | 9060095 | Chest pain | |
| 90600951 | 9060095 | Coronary artery occlusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 90600951 | 9060095 | CSM |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 90600951 | 9060095 | 1 | 20120103 | 20120528 | 0 |